The posting of sponsored information and content on this page should not be considered an AAFP endorsement or recommendation of the sponsor's products, services, policies, or procedures. The information and opinions expressed on this page are those of the paid sponsors and do not necessarily reflect the view of the AAFP. The AAFP is not responsible for the content of third-party websites linked from this page; moreover, any links on this page to third-party websites where goods or services are advertised are not endorsements or recommendations by the AAFP of the third-party sites, goods, or services.
The following sponsor-developed resources may be of interest:
Through this video presentation, you will learn about the clinical benefits of the first line screen test for autoimmune diseases. ANA testing by IFA microscopy is a highly sensitive test for detecting up to 150 antibodies and is the gold standard set by the American College of Rheumatology. ANA IFA testing in the correct clinical setting can lead to early diagnosis and treatment of devastating diseases. ANA IFA uses HEp-2 human tissue culture cells to detect autoantibodies directed against antigens in the cell nucleus and cytoplasm. A fluorescent microscope is used to view fluorescent-labeled ANAs. When results are positive, various fluorescent staining patterns are observed and are reported along with the titer. The patterns are associated with different autoimmune disorders. Higher titers are generally associated with greater likelihood of disease, but do not reflect disease activity. Advanced testing through a 3 tiered algorithm can be an effective way to help make an early diagnosis of the more common rheumatic diseases. Eight case studies are reviewed to educate the physician on how clinical and lab findings can be used to help make an early diagnosis.
Do you regularly get questions about low calorie sweeteners? Access quick-to-scan summaries, along with citations, of recent scientific research supporting the safety and efficacy of low calorie sweeteners in the 2017 update of this practical resource. It’s compiled for you – the busy family practice physician compliments of SPLENDA® Sweeteners.
What do physicians need to know about hospice and palliative services, goals of care conversations, advance directives and other issues that become more important as curative therapies become less effective? VITAS Healthcare, the nation’s oldest and largest hospice care provider, offers a monthly series of webinars that cover everything from the ethics of end-of-life care to the palliation of pain. Put your patient in control. Help them understand the trajectory of their disease and their options at every step along the way. VITAS can help.
We asked physician recruiters at healthcare facilities around the country who have extensive experience interviewing physicians what their ideal answers would be to the most frequently asked interview questions. From good ways to respond to “Tell me about yourself” to suggestions for the best answer for “What are you strengths and weaknesses?” Click the link get the answers to these and other regularly asked questions to help you prepare for your next interview.
Influenza immunization can be a complex and daunting undertaking involving activities related to reservation of vaccine, shipping and delivery, coding/reimbursement, and in-office patient education activities. Sanofi Pasteur is dedicated to helping providers achieve their immunization goals through a direct relationship this influenza season.
The Ask the Expert webinar series from CHADD, the leading resource on ADHD, provides education for the 17 million children and adults in the United States living with ADHD, their families, healthcare professionals and educators. CHADD’s National Resource Center on ADHD (NRC) partners with leading experts in the field of ADHD with the Ask the Expert webinars to bring reliable, science-based information regarding current medical research and ADHD management to each of these audiences.
Help Your Patients Quit Smoking Tobacco use remains the leading cause of preventable death and disease in the U.S., killing close to half a million people each year. The American Lung Association is committed to ending the death and disease caused by tobacco use. Widely regarded as the “Gold Standard” in quit-smoking programs, Freedom From Smoking® was created by the experts at the American Lung Association—an organization with more than 50 years of experience helping smokers quit. Freedom From Smoking® Plus is the American Lung Association’s online tobacco cessation course that offers an engaging behavior change experience designed for today’s mobile lifestyles.